Nestle has a newly-acquired company, and it is the protein shake maker, Orgain. The latter produces plant-based bars, shakes, and protein powders, and the Swiss multinational food and drink processing company headquartered in Vevey, Vaud, Switzerland, bought a majority stake for an undisclosed amount.
Andrew Abraham, Orgain's founder, and Butterfly Equity will remain shareholders of the company once the deal is completed. According to Food Dive, the agreement between Nestle and Orgain includes the option for the former to buy the rest of the shares in the company in 2024. Abraham will also retain his position as the chief executive officer of Orgain.
It was said that the stake acquisition will push and step up Nestlé's efforts to grow its health and wellness business unit. To attain its goal, the company will also be removing some of its divisions that are growing slowly compared to the others.
In fact, Nestlé already offloaded its confections and ice cream businesses and last year, it has also disposed of the majority of its North American bottled waters business for $4.3 billion as it was already struggling to stay afloat.
With its new deal with Orgain, Nestle will also be able to focus more on its other international premium brands that have big potential to grow further such as Perrier. Orgain will also give the firm fresh products to offer especially with the growing demand for plant-based items around the world. Furthermore, Orgain will give Nestle a deeper presence in trendy categories that are becoming really popular with consumers.
"Nutritional protein plays a key role in supporting our health and wellness, whether we enjoy an active lifestyle or are facing health challenges," Nestlé Health Science chief executive officer, Greg Behar, said in a press release. "Orgain's emphasis on clean, all natural, plant-based, organic ingredients has made it a leader in the U.S., and we look forward to combining our companies' expertise to bring Orgain to more people around the world."
Dr. Abraham, CEO and Founder of Orgain, also said, "We've worked hard to develop innovative products that make a real difference in consumers' lives, and now through Nestlé Health Science's capabilities, resources and dedication to nutrition, we will be able to reach more people around the world."
Meanwhile, the acquisition deal is still subject to customary regulatory approvals.


OpenAI Eyes IPO Filing as Early as This Week Amid Rising AI Competition
Spying, Southampton and economic pressure cooker of the ‘richest match in football’
China to Buy 200 Boeing Jets, Push for Extended U.S. Trade Deal
Nvidia Beats Earnings Expectations as AI Demand Drives Record Growth
Asian Stocks Rally as Nvidia Earnings Boost Tech Shares, Samsung Jumps on Wage Deal
Dollar Eases as US-Iran Peace Deal Report Impacts Forex and Bond Markets
Iran-U.S. Talks Continue as Strait of Hormuz and Uranium Dispute Stall Peace Efforts
Japan Inflation Falls Below BOJ Target as Energy Subsidies Ease Consumer Pressure
Trump Signals Tough Stance on Iran Uranium Stockpile as Nuclear Talks Show Limited Progress
Gold Prices Slip as Iran Conflict and Fed Rate Hike Fears Weigh on Market Sentiment
SoftBank Shares Surge as OpenAI IPO Buzz and SB Energy Filing Boost AI Optimism
Anthropic Revenue Surge Signals Strong AI Market Momentum in 2026
NHS shakeup: if it sounds like we’ve been here before, it’s because we have
Rubio to Push NATO Defense Spending, Strengthen India Ties During Key Diplomatic Tour
Cuba needs a long-term solution to its energy crisis
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
Japan Airlines Signs 10-Year Boeing 787 Maintenance Deal With GE Aerospace 



